CTKB Insider Trading

Insider Ownership Percentage: 9.60%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Cytek Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Cytek Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$1M$0$1MTotal Insider BuyingTotal Insider Selling

Cytek Biosciences Share Price & Price History

Current Price: $3.75
Price Change: Price Decrease of -0.11 (-2.85%)
As of 04/29/2025 05:00 PM ET

This chart shows the closing price history over time for CTKB up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JunJulAugSepOctNovDecJanFebMarApr$3.75Closing price on 04/29/25:

SEC Filings (Institutional Ownership Changes) for Cytek Biosciences (NASDAQ:CTKB)

69.46% of Cytek Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CTKB by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$1.53Mbought$201ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$20M-$10M$0$10M$20MTotal InflowsTotal Outflows
Cytek Biosciences logo
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Read More on Cytek Biosciences

Today's Range

Now: $3.75
Low: $3.70
High: $3.85

50 Day Range

MA: $4.08
Low: $3.37
High: $5.22

52 Week Range

Now: $3.75
Low: $3.27
High: $7.63

Volume

444,528 shs

Average Volume

715,605 shs

Market Capitalization

$480.36 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.41

Who are the company insiders with the largest holdings of Cytek Biosciences?

Cytek Biosciences' top insider investors include:
  1. Ming Yan (CTO)
  2. Wenbin Jiang (CEO)
  3. Patrik Jeanmonod (CFO)
Learn More about top insider investors at Cytek Biosciences.

Who are the major institutional investors of Cytek Biosciences?

Cytek Biosciences' top institutional investors include:
  1. Principal Financial Group Inc. — 0.41%
  2. Acuitas Investments LLC — 0.26%
  3. Teacher Retirement System of Texas — 0.07%
  4. Summit Global Investments — 0.04%
  5. New York State Teachers Retirement System — 0.04%
  6. Diversified Trust Co — 0.02%
Learn More about top institutional investors of Cytek Biosciences stock.

Which institutional investors are selling Cytek Biosciences stock?

Within the last quarter, CTKB stock was sold by these institutional investors:
  1. Teacher Retirement System of Texas

Which institutional investors are buying Cytek Biosciences stock?

During the last quarter, CTKB stock was bought by institutional investors including:
  1. Acuitas Investments LLC
  2. Diversified Trust Co
  3. Summit Global Investments
  4. Wealth Enhancement Advisory Services LLC
  5. Principal Financial Group Inc.
  6. New York State Teachers Retirement System